UNRESECTABLE HEPATOCELLULAR CARCINOMA
Clinical trials for UNRESECTABLE HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail therapy aims to shrink untreatable liver tumors
Disease control Not yet recruitingThis study tests a four-drug combination for people with advanced liver cancer that cannot be surgically removed. The treatment includes radioactive beads injected into the liver, two immunotherapy drugs that boost the immune system, and a pill that blocks cancer growth. The goal…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated May 17, 2026 02:08 UTC
-
New combo attack shrinks untreatable liver tumors
Disease control Not yet recruitingThis study tests a powerful mix of treatments for people with liver cancer that cannot be surgically removed. It combines two types of local therapy (TACE and SBRT) with an immunotherapy drug and a targeted pill (donafenib). The goal is to see if this combination can shrink tumor…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
New radiation therapy could shrink liver tumors and open door to transplant
Disease control Not yet recruitingThis study tests a precise radiation treatment (Yttrium-90) for people with liver cancer that cannot be surgically removed. The treatment delivers tiny radioactive beads directly to the tumor's blood supply to shrink it. The goal is to see how well it controls the cancer and whet…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
Lab-Grown mini tumors could pick the right drug for liver cancer patients
Disease control Not yet recruitingThis study tests whether growing a patient's liver cancer cells in a lab and testing different drugs on them can help doctors choose the most effective treatment. About 94 adults with advanced liver cancer that cannot be removed by surgery will either receive standard therapy or …
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Eastern Hepatobiliary Surgery Hospital • Aim: Disease control
Last updated May 07, 2026 18:41 UTC